Malnutrition is an Independent Risk Factor on Survival on EGFR Mutated Patients Diagnosed with Non-Small Cell Lung Cancer

被引：0
作者：
De la Torre-Vallejo, Martha
Luvian-Morales, Julissa
Gonzalez-Ling, Ana
Turcott, Jenny
Arrieta, Oscar
机构：
[1] Inst Nacl Cancerol, Thorac Oncol Unit, Mexico City, DF, Mexico
[2] Inst Nacl Cancerol, Lab Personalized Med, Mexico City, DF, Mexico
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 01期
关键词：
D O I：
10.1016/j.jtho.2016.11.2164
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3.05-002
引用
收藏
页码：S1413 / S1413
页数：1
相关论文
共 50 条
[31]   RNA Sequencing to Characterize Pathways in Patients with EGFR-mutated Non-Small Cell Lung Cancer [J].
Yun, N. K. ;
Pope, C. ;
Cagin, K. M. ;
Naqib, A. ;
Borgia, J. A. ;
Fidler, M. J. .
JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) :S449-S449
[32]   Therapeutic strategies for EGFR-mutated non-small cell lung cancer patients with osimertinib resistance [J].
Fu, Kai ;
Xie, Fachao ;
Wang, Fang ;
Fu, Liwu .
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2022, 15 (01)
[33]   Are EGFR tyrosine kinase inhibitors effective in elderly patients with EGFR-mutated non-small cell lung cancer? [J].
Roviello, Giandomenico ;
Zanotti, Laura ;
Cappelletti, Maria Rosa ;
Gobbi, Angela ;
Dester, Martina ;
Paganini, Giovanni ;
Pacifico, Chiara ;
Generali, Daniele ;
Roudi, Raheleh .
CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 18 (01) :15-20
[34]   Liquid Biopsies in Patients with EGFR Mutated Non-Small Cell Lung Cancer Undergoing Curative Treatment [J].
Hansen, Eva B. ;
Sorensen, Boe S. ;
Meldgaard, Peter .
JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) :S607-S607
[35]   Pharmacokinetics of edoxaban in EGFR-mutated non-small cell lung cancer patients with venous thromboembolism [J].
Hotta, Takamasa ;
Tsubata, Yukari ;
Hamai, Kosuke ;
Tanino, Akari ;
Kobayashi, Misato ;
Nakamura, Atsushi ;
Sugisaka, Jun ;
Hongoh, Masafumi ;
Ishihara, Noriyuki ;
Ishikawa, Nobuhisa ;
Yamasaki, Masahiro ;
Fujitaka, Kazunori ;
Kubota, Tetsuya ;
Nishimura, Nobuhiro ;
Isobe, Takeshi .
RESPIRATORY INVESTIGATION, 2021, 59 (03) :327-334
[36]   Are EGFR tyrosine kinase inhibitors effective in elderly patients with EGFR-mutated non-small cell lung cancer? [J].
Giandomenico Roviello ;
Laura Zanotti ;
Maria Rosa Cappelletti ;
Angela Gobbi ;
Martina Dester ;
Giovanni Paganini ;
Chiara Pacifico ;
Daniele Generali ;
Raheleh Roudi .
Clinical and Experimental Medicine, 2018, 18 :15-20
[37]   Therapeutic strategies for EGFR-mutated non-small cell lung cancer patients with osimertinib resistance [J].
Kai Fu ;
Fachao Xie ;
Fang Wang ;
Liwu Fu .
Journal of Hematology & Oncology, 15
[38]   EGFR Genotype as a Predictor of Survival in EGFR Mutant Non-Small Cell Lung Cancer [J].
Syrigos, K. ;
Tsagouli, S. ;
Gkiozos, I. ;
Paraskeva, M. ;
Kotteas, I. ;
Tsimpoukis, S. ;
Zontanos, M. ;
Grapsa, D. .
JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) :S903-S903
[39]   Osimertinib in untreated epidermal growth factor receptor (EGFR)-mutated advanced non-small cell lung cancer [J].
Gregorc, Vanesa ;
Lazzari, Chiara ;
Karachaliou, Niki ;
Rosell, Rafael ;
Santarpia, Mariacarmela .
TRANSLATIONAL LUNG CANCER RESEARCH, 2018, 7 :S165-S170
[40]   Leptomeningeal carcinomatosis from EGFR-mutated non-small cell lung cancer [J].
Iuchi, T. ;
Shingyoji, M. ;
Setoguchi, T. ;
Yoshida, Y. ;
Ashinuma, H. ;
Hasegawa, Y. ;
Sakaida, T. .
ANNALS OF ONCOLOGY, 2017, 28
12345